JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB182858

Anti-Bcl-2 抗体 [EPR17509]

Anti-Bcl-2 antibody [EPR17509]

  • BOND RX™ Validated
  • RabMAb
  • Recombinant
  • KO Validated
  • 20ul selling size
  • 詳細を見る

5

(13 Reviews)

|

(1084 Publications)

Anti-Bcl-2 antibody [EPR17509] (ab182858) is a rabbit monoclonal antibody detecting Bcl-2 in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IHC-P. Suitable for Human, Mouse.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 630 publications

別名を表示する

Apoptosis regulator Bcl-2, BCL2

12 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [EPR17509] (AB182858)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [EPR17509] (AB182858)

Immunohistochemical analysis of paraffin-embedded Human endometrial cancer tissue labeling Bcl-2 with ab182858 at 1/1000 followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500.

Cytoplasm, nuclear membrane and nucleus staining on lymphocytes and cancer cells of Human endometrial cancer tissue is observed.

Counter stained with Hematoxylin.
Negative control : Used PBS instead of primary antibody followed by ab97051 at 1/500.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [EPR17509] (AB182858)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [EPR17509] (AB182858)

Immunohistochemical analysis of formalin fixed paraffin embedded human spleen labelling Bcl-2 with ab182858 at a concentration of 0.32µg/ml. The immunostaining was performed on a Leica Biosystems BOND ® RX instrument with a Bond™ Polymer Refine Detection kit. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution 2) for 20mins.

ab182858 anti-Bcl-2 antibody [EPR17509] was incubated for 15mins at room temperature. Sections were counterstained with Hematoxylin. Image inset shows absence of staining in secondary antibody only control.

Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual)

Flow Cytometry (Intracellular) - Anti-Bcl-2 antibody [EPR17509] (AB182858)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-Bcl-2 antibody [EPR17509] (AB182858)

Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed Jurkat (Human T cell leukemia cells from peripheral blood) cells labeling Bcl-2 with ab182858 at 1/250 (red) compared with a rabbit monoclonal IgG isotype control (ab172730) (black) and a unlabelled control (cells without incubation with primary antibody and secondary antibody (blue)). Goat anti rabbit IgG (FITC) at 1/500 was used as the secondary antibody.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [EPR17509] (AB182858)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [EPR17509] (AB182858)

Immunohistochemical analysis of paraffin-embedded human tonsil tissue labeling Bcl-2 with ab182858 at 1/1000 followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500.

Cytoplasm, nuclear membrane and nucleus staining on lymphocytes of Human tonsil tissue is observed.

Counter stained with Hematoxylin.

Negative control : Used PBS instead of primary antibody followed by ab97051 at 1/500.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [EPR17509] (AB182858)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [EPR17509] (AB182858)

Immunohistochemical analysis of formalin fixed paraffin embedded human spleen labelling Bcl-2 with ab182858 at a concentration of 0.86µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins.

ab182858 anti-Bcl-2 antibody [EPR17509] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.

Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [EPR17509] (AB182858)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [EPR17509] (AB182858)

Immunohistochemical analysis of paraffin-embedded Mouse spleen tissue labeling Bcl-2 with ab182858 at 1/1000 followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500.

Cytoplasm, nuclear membrane and nucleus staining on lymphocytes of Mouse spleen tissue is observed.

Counter stained with Hematoxylin.
Negative control : Used PBS instead of primary antibody followed by ab97051 at 1/500.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Western blot - Anti-Bcl-2 antibody [EPR17509] (AB182858)
  • WB

Lab

Western blot - Anti-Bcl-2 antibody [EPR17509] (AB182858)

Lanes 1 - 4 : Merged signal (red and green). Green - ab182858 observed at 26 kDa. Red - loading control, ab8245, observed at 37 kDa.

ab182858 was shown to specifically react with BCL2 when BCL2 knockout samples were used. Wild-type and BCL2 knockout samples were subjected to SDS-PAGE. ab182858 and ab8245 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1 ug/ml and 1/10000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Bcl-2 antibody [EPR17509] (ab182858) at 1 µg/mL

Lane 1:

Wild-type HAP1 whole cell lysate at 20 µg

Lane 2:

BCL2 knockout HAP1 whole cell lysate at 20 µg

Lane 3:

HeLa whole cell lysate at 20 µg

Lane 4:

THP-1 whole cell lysate at 20 µg

Predicted band size: 26 kDa

Observed band size: 26 kDa

false

Western blot - Anti-Bcl-2 antibody [EPR17509] (AB182858)
  • WB

Lab

Western blot - Anti-Bcl-2 antibody [EPR17509] (AB182858)

Lanes 1- 2 : Merged signal (red and green). Green - ab182858 observed at 26 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.

ab182858 was shown to react with Bcl-2 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab255364 (knockout cell lysate ab263752) was used. Wild-type HeLa and BCL2 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab182858 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 2000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Bcl-2 antibody [EPR17509] (ab182858) at 1/2000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

BCL2 knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human BCL2 knockout HeLa cell line (<a href='/products/cell-lines/human-bcl2-knockout-hela-cell-line-ab255364'>ab255364</a>)

Predicted band size: 26 kDa

Observed band size: 26 kDa

false

Western blot - Anti-Bcl-2 antibody [EPR17509] (AB182858)
  • WB

Supplier Data

Western blot - Anti-Bcl-2 antibody [EPR17509] (AB182858)

Blocking and diluting buffer was 5% NFDM /TBST.

All lanes:

Western blot - Anti-Bcl-2 antibody [EPR17509] (ab182858) at 1/2000 dilution

Lane 1:

Human fetal kidney lysate at 10 µg

Lane 2:

Human fetal spleen lysate at 10 µg

Secondary

All lanes:

Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution

Predicted band size: 26 kDa

Observed band size: 26 kDa

true

Exposure time: 3min

Western blot - Anti-Bcl-2 antibody [EPR17509] (AB182858)
  • WB

Supplier Data

Western blot - Anti-Bcl-2 antibody [EPR17509] (AB182858)

Blocking and diluting buffer was 5% NFDM /TBST.

All lanes:

Western blot - Anti-Bcl-2 antibody [EPR17509] (ab182858) at 1/2000 dilution

Lane 1:

Mouse brain lysate at 10 µg

Lane 2:

Mouse heart lysate at 10 µg

Lane 3:

Mouse kidney lysate at 10 µg

Lane 4:

Mouse spleen lysate at 10 µg

Lane 5:

NIH/3T3 (Mouse embryo fibroblast cell line) whole cell lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/1000 dilution

Predicted band size: 26 kDa

Observed band size: 26 kDa

true

Exposure time: 3min

Western blot - Anti-Bcl-2 antibody [EPR17509] (AB182858)
  • WB

Lab

Western blot - Anti-Bcl-2 antibody [EPR17509] (AB182858)

Blocking/Diluting buffer 5% NFDM/TBST

All lanes:

Western blot - Anti-Bcl-2 antibody [EPR17509] (ab182858) at 1/10000 dilution

Lane 1:

NIH/3T3 (mouse embryo fibroblast cell line) whole cell lysate at 20 µg

Lane 2:

WEHI-3 (mouse leukemia cell line) whole cell lysate at 20 µg

Lane 3:

Mouse hippocampus at 10 µg

Lane 4:

Mouse heart at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG H&L (HRP) at 1/2000 dilution

Predicted band size: 26 kDa

Observed band size: 26 kDa

false

Exposure time: 8s

Western blot - Anti-Bcl-2 antibody [EPR17509] (AB182858)
  • WB

Supplier Data

Western blot - Anti-Bcl-2 antibody [EPR17509] (AB182858)

Blocking and diluting buffer was 5% NFDM /TBST.

All lanes:

Western blot - Anti-Bcl-2 antibody [EPR17509] (ab182858) at 1/20000 dilution

Lane 1:

Human tonsil lysate at 20 µg

Lane 2:

Human thymus lysate at 20 µg

Lane 3:

Jurkat (Human T cell leukemia cells from peripheral blood) whole cell lysate at 20 µg

Lane 4:

U-937 (Human histiocytic lymphoma cells) whole cell lysate at 20 µg

Lane 5:

THP-1 (Human monocytic leukemia cells) whole cell lysate at 20 µg

Lane 6:

HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate at 20 µg

Lane 7:

C2C12 (Mouse myoblast cell line) whole cell lysate at 20 µg

Lane 8:

WEHI-3 (Mouse leukemia cell line) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/1000 dilution

Predicted band size: 26 kDa

Observed band size: 26 kDa

true

Exposure time: 1min

関連する標識済み抗体及び組成の異なる製品 (2)

  • Carrier free

    Anti-Bcl-2 antibody [EPR17509] - BSA and Azide free

  • HRP

    HRP Anti-Bcl-2 antibody [EPR17509]

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EPR17509

アイソタイプ

IgG

キャリアフリー

No

交差種

Mouse, Human

アプリケーション

Flow Cyt (Intra), IHC-P, WB

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "1/150", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/250", "FlowCytIntra-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/500", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "1/150", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/500", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." } } }

製品の詳細

Anti-Bcl-2 antibody [EPR17509] (ab182858) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), IHC-P and WB.

Anti-Bcl-2 antibody [EPR17509] (ab182858) was first used in a scientific publication in 2016 and has been cited over 632 times in peer reviewed journals. It's performance in Western Blot in human and mouse samples is trusted by the scientific community.

Abcam's high quality manufacturing and validation processes ensure Anti-Bcl-2 antibody [EPR17509] (ab182858) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.

The specificity of Anti-Bcl-2 antibody [EPR17509] (ab182858) has been confirmed by Western Blot testing in Bcl-2 knockout HeLa cells (ab263752).

Anti-Bcl-2 antibody [EPR17509] (ab182858) has 13 independent reviews from customers.

Anti-Bcl-2 antibody [EPR17509] (ab182858) specifically detects Bcl-2 (UniProt ID: P10415; Molecular weight: 27kDa) and is sold in 100 µL and 1 mL selling sizes.

Conjugation-ready, carrier free format available for antibody clone EPR17509 - ab219608.

Antibody clone EPR17509 is also available pre-conjugated to a variety of labels for your convenience - HRP (ab209039).

B-cell lymphoma 2 (Bcl-2) is a key protein in oncology, known for its role in regulating apoptosis, or programmed cell death. It promotes cell survival by inhibiting pro-apoptotic proteins, thereby preventing apoptosis and contributing to the development and progression of various cancers.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Bcl-2 also known as B-cell lymphoma 2 is an important protein involved in the regulation of apoptosis. It mechanically functions by inhibiting cell death and is a member of the Bcl-2 family of proteins. Bcl-2 has a molecular weight of approximately 26 kDa. It is expressed mainly in fetal and adult tissues including the immune system and is notably present in hematopoietic stem cells and various cell lines derived from lymphoid tissues. In laboratory practices scientists often assess Bcl-2 expression levels through techniques like western blotting using antibodies such as 10c4 for detection.
Biological function summary

The role of Bcl-2 extends to maintaining cell survival and balancing apoptotic signals. It functions as an anti-apoptotic molecule within the cell primarily involved in forming complexes with pro-apoptotic members of the Bcl-2 family like Bax and Bak. These interactions prevent mitochondrial membrane permeabilization which is an important step in apoptotic signal transduction. As an important regulator of apoptosis Bcl-2 helps in cellular homeostasis and appropriate immune responses under physiological conditions.

Pathways

Bcl-2 plays a critical role in the intrinsic or mitochondrial pathway of apoptosis. Within this pathway Bcl-2 interacts with other proteins such as cytochrome c and APAF-1 to inhibit apoptosis. This pathway involves a network of Bcl-2 family proteins where Bcl-2's anti-apoptotic role counteracts the pro-apoptotic activity of proteins like Bax. These interactions help fine-tune the apoptotic response to various internal stimuli maintaining cellular integrity and function.

The dysregulation of Bcl-2 expression has been implicated in cancer and autoimmune diseases. Overexpression of Bcl-2 is associated with several types of cancer including lymphomas and breast cancer where its anti-apoptotic property leads to tumor cell survival and resistance to chemotherapy. Bcl-2 also connects to disorders such as autoimmune diseases due to its regulation of cell survival with proteins like Bim playing an opposite role in promoting apoptosis. Understanding Bcl-2's functionality within these contexts is essential for developing targeted therapies.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells (PubMed : 1508712, PubMed : 8183370). Regulates cell death by controlling the mitochondrial membrane permeability (PubMed : 11368354). Appears to function in a feedback loop system with caspases (PubMed : 11368354). Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (PubMed : 11368354). Also acts as an inhibitor of autophagy : interacts with BECN1 and AMBRA1 during non-starvation conditions and inhibits their autophagy function (PubMed : 18570871, PubMed : 20889974, PubMed : 21358617). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (PubMed : 17418785).
See full target information BCL2

文献 (1084)

Recent publications for all applications. Explore the full list and refine your search

The Tohoku journal of experimental medicine : PubMed41062300

2025

Identification of KLHL35, WDR72, and WDR78 as Prognostic Biomarkers in Colorectal Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jiayou Ye,Tingting Zhang,Guangsheng Wang,Guofeng Bian,Aijun Chen,Xin Zhou

Acta pharmaceutica Sinica. B 15:4945-4960 PubMed41049731

2025

Photodynamic enhancement of PROTAC prodrug activation in hypoxic tumors.

Applications

Unspecified application

Species

Unspecified reactive species

Zhongliang Fu,Chunrong Yang,Yuchen Yang,Meichen Pan,Hongwei Hou,Jinghong Li

The Tohoku journal of experimental medicine : PubMed41034038

2025

Acupuncture Ameliorates Cognitive Dysfunction by Modulating the Apoptosis of Hippocampal Neuron in Severe Hand Foot and Mouth Disease Infant Rats Through the p38 MAPK/CREB Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Zongtao Wu,Hongjiao Jin,Biqin Shuai,Xiang Zhang,San Wang,Lan Chen,Bo Huang

Oncology letters 30:522 PubMed40995140

2025

ARHGEF6 downregulation as a key mediator of tumor cell apoptosis in breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Yang Zhang,Dandan Zhou,Xuting Shen,Qinqin Song,Liuyang Yang,Wenbo Li,Xinxin Zhao,Wenxiang Fang,Bian Liu,Chencen Xing,Jisong Liu,Haoshu Fang,Qilun Zhang

Journal of cellular and molecular medicine 29:e70799 PubMed40922382

2025

The Role of Endometriosis in Intestinal Inflammation: A Combined Mendelian Randomization and Cellular Study.

Applications

Unspecified application

Species

Unspecified reactive species

Zhigang Li,Fang Wang,Ernv Kang,Xiaoguang Zhen,Jianli Liu,Wenhao Wang

Science and technology of advanced materials 26:2504867 PubMed40895183

2025

Photothermal-gas combination therapy promotes checkpoint blockade immunotherapy in colon cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Benchao Zheng,Hongbo Wang,Shiyi Zhai,Jiangsheng Li,Kuangda Lu

Cells 14: PubMed40862741

2025

Chromatin Remodeler RSF1 as an Oncogenic Driver and Therapeutic Target in Esophageal Squamous Cell Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Zhenhua Du,Zhili Jia,Yao Lin,Xudong Zhao,Gengsheng Cao,Hengbin Wang

Theranostics 15:8176-8201 PubMed40860154

2025

An unrecognized mechanism of self-protection in degenerating neurons mediated by astrocytic YAP through Wnts/β-catenin/EAAT2 signaling in C9orf72-poly-GA mice.

Applications

Unspecified application

Species

Unspecified reactive species

Dongmei Li,Yan Wei,Rui Yang,Xuan Luo,Yanzhu Liu,Weiqiao Zhao,Hui Yang,Yumin Wu,Ying Wang,Zhihui Huang

Natural products and bioprospecting 15:56 PubMed40839202

2025

Dual inhibition of FAS and HAS2/3 by 4-MU in Realgar-Coptis chinensis unveils a metabolic checkpoint for liver cancer therapy.

Applications

Unspecified application

Species

Unspecified reactive species

Songtao Wu,Yingying Wang,Denghui Deng,Guohua Zheng,Hanxiang Mei,Cong Wang,Xiang Zheng,Chun Gui,Fei Liao,Meixian Xiang

American journal of translational research 17:5332-5343 PubMed40821094

2025

Endothelial progenitor cell-derived microvesicles therapy relieves myocardial infarction symptoms by altering left ventricular protein expression.

Applications

Unspecified application

Species

Unspecified reactive species

Yanling Song,Shuai Wang,Huade Mai,Minghui Chen,Yunyun Lin,Huajun Wu,Shenhong Gu
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com